Why Is Unity Biotechnology (UBX) Stock Down 52% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Unity Biotechnology (UBX) stock is taking a beating on Monday after revealing results from its Phase 2 clinical trial of UBX1325. The post Why Is Unity Biotechnology (UBX) Stock Down 52% Today? appeared first on InvestorPlace . More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today It doesn’t matter if you have $500 or $5 million. Do this now. Massive Bear Market “Divergence Event” Ahead… And The #1 Way to Play It